Padmaja Yerramilli-Rao

Padmaja Yerramilli-Rao currently serves as the Senior Vice President and Head of Clinical Development at Treeline Biosciences since April 2025. Prior to this role, Padmaja spent several years at Novartis Institutes for BioMedical Research (NIBR), where positions included US Clinical Site Head and Executive Director in the field of Translational Clinical Oncology from January 2017 to May 2025. Earlier experience includes a Research Fellow position at Massachusetts General Hospital from July 2009 to December 2011 and a Physician role at the National Health Service from February 2001 to June 2009. Padmaja holds a PhD in Neuroscience from King's College London and an MB BS in Medicine from St George's, University of London.